DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20183286

Neuropathic pruritus: an early indicator of neuromyelitis optica spectrum disorders

Pradeep Kumar Bansal, C. L. Nawal, Aradhana Singh, Radheyshyam Chejara, Sebastian Marker, Pankaj Mangal

Abstract


Neuromyelitis optica is a relapsing, inflammatory astrocytopathic disorder, affecting predominantly the optic nerves and spinal cord. It is associated with antiaquaporin-4 immunoglobulin G (AQP4-IgG) in up to 70% of patients. Spinal cord involvement typically presents as a longitudinally-extensive transverse myelitis, with associated sensorimotor and sphincter dysfunction. Sensory symptoms such as numbness, dysaesthesia, pain and tonic spasms are common. Here, we present a case of a 25years old female who came to the medicine OPD, with the chief complaints of intense itching over face and forehead, which was later on progressed to quadriparesis after 3 weeks. This case highlights neuropathic pruritus as an under-recognised early feature of neuromyelitis optica.


Keywords


AQP4-IgG, NMOSD, Neuropathic pruritus

Full Text:

PDF

References


Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473Y477.

Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964Y968.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 Feb 5;130(5):1194-205.

Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11;69(24):2221-31.

Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurol. 2005 Nov 8;65(9):1479-82.

Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Annals Neurol. 2010 Nov;68(5):757-61.

Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K, et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry. 2008 Apr 17.

De Seze J, Kremer L, Collongues N. Neuromyelitis optica spectrum disorder (NMOSD): a new concept. Rev Neurol. 2016;172:256-62.

Hamid SH, Mutch K, Elsone L, Solomon T, Jacob A. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates. Mult Scler J. 2016;23:228-33.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235.

Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Multiple Sclerosis J. 2014 Jun;20(7):843-7.

Matthews W. The symptoms and signs of multiple sclerosis. In: Compston A, ed. McAlpine’s multiple sclerosis. 4th edn. Philadelphia: Churchill Livingstone, 2006:326.

Elsone L, Townsend T, Mutch K, Das K, Boggild M, Nurmikko T, et al. Neuropathic pruritus (itch) in neuromyelitis optica. Multiple Sclerosis J. 2013 Apr;19(4):475-9.

Ikoma A. Updated neurophysiology of itch. Biol Pharm Bull. 2013;36:1235-40.

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-9.

Yang X, Ransom BR, Ma JF. The role of AQP4 in neuromyelitis optica: more answers, more questions. J Neuroimmunol. 2016;298:63-70.

Tüzün E, Tzartos J, Ekizoğlu E, et al. Aquaporin-1 antibody in neuromyelitis optical patients. Tzartos S Eur Neurol. 2014;72:271-272.

Steinman L, Bar-Or A, Behne JM, Benitez-Ribas D, Chin PS, Clare-Salzler M, et al. Restoring immune tolerance in neuromyelitis optica: part I. Neurology-Neuroimmunol Neuroinflamma. 2016;3(5):e276.

Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol. 2010;12:244-55.

Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2014 Jan 1;261(1):1-6.